Prediction of HIV acquisition among men who have sex with men

Sexually Transmitted Diseases

Volumn 36, Issue 9, 2009, Pages 547-555

  Menza, Timothy W ^a,b,c   Hughes, James P ^a   Celum, Connie L ^a   Golden, Matthew R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METHAMPHETAMINE; NITRITE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANUS INTERCOURSE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG ABUSE; ENZYME IMMUNOASSAY; FOLLOW UP; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MODEL; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE;

ADULT; AMPHETAMINE-RELATED DISORDERS; CLINICAL TRIALS AS TOPIC; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MEDICAL RECORDS; METHAMPHETAMINE; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES; UNSAFE SEX; YOUNG ADULT;

EID: 70349445220     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181a9cc41     Document Type: Article

References (59)

1. Subpopulation estimates from the HIV incidence surveillance system-United States, 2006. MMWR Morb Mortal Wkly Rep 2008; 57:985-989.
2. Hall HI, Song R, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA 2008; 300:520-529.
3. Baral S, Sifakis F, Cleghorn F, et al. Elevated risk for HIV infection among men who have sex with men in low-and middle-income countries 2000-2006: A systematic review. PLoS Med 2007; 4:e339.
4. Buchbinder SP, Vittinghoff E, Heagerty PJ, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr 2005; 39:82-89.
5. Koblin BA, Husnik MJ, Colfax G, et al. Risk factors for HIV infection among men who have sex with men. AIDS 2006; 20:731-739.
6. Hall HI, Byers RH, Ling Q, et al. Racial/ethnic and age disparities in HIV prevalence and disease progression among men who have sex with men in the United States. Am J Public Health 2007; 97:1060-1066.
7. Plankey MW, Ostrow DG, Stall R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconver-sion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2007; 45:85-92.
8. Schwarcz SK, Kellogg TA, McFarland W, et al. Characterization of sexually transmitted disease clinic patients with recent human immunodeficiency virus infection. J Infect Dis 2002; 186:1019-1022.
9. Lloyd-Jones DM, Larson MG, Beiser A, et al. Lifetime risk of developing coronary heart disease. Lancet 1999; 353:89-92.
10. Griffin SJ, Little PS, Hales CN, et al. Diabetes risk score: Towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16:164-171.
11. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81:1879-1886.
12. Tice JA, Cummings SR, Smith-Bindman R, et al. Using clinical factors and mammographic breast density to estimate breast cancer risk: Development and validation of a new predictive model. Ann Intern Med 2008; 148:337-347.
13. Cassidy A, Duffy SW, Myles JP, et al. Lung cancer risk prediction: A tool for early detection. Int J Cancer 2007; 120:1-6.
14. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864-2870.
15. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
16. Bach PB, Niewoehner DE, Black WC. Screening for lung cancer: The guidelines. Chest 2003; 123(suppl 1):83S-88S.
17. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
18. Qaseem A, Snow V, Sherif K, et al. Screening mammography for women 40 to 49 years of age: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2007; 146:511-515. (Pubitemid 351650560)
19. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114:e257-e354. (Pubitemid 44252297)
20. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2007; 30(suppl 1):S48-S65.
21. Boileau C, Bruneau J, Al-Nachawati H, et al. A prognostic model for HIV seroconversion among injection drug users as a tool for stratification in clinical trials. J Acquir Immune Defic Syndr 2005; 39:489-495.
22. Chen Z, Branson B, Ballenger A, et al. Risk assessment to improve targeting of HIV counseling and testing services for STD clinic patients. Sex Transm Dis 1998; 25:539-543.
23. Richert CA, Peterman TA, Zaidi AA, et al. A method for identifying persons at high risk for sexually transmitted infections: Opportunity for targeting intervention. Am J Public Health 1993; 83:520-524.
24. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387.
25. Stekler J, Swenson PD, Wood RW, et al. Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS 2005; 19:1323-1325.
26. Slide Set: HIV/AIDS Surveillance in Men Who Have Sex with Men (MSM). Available at: http://www.cdc.gov/hiv/topics/ surveillance/resources/slides/msm/ index.htm. Accessed November 21, 2008.
27. Choi KH, McFarland W, Neilands TB, et al. An opportunity for prevention: Prevalence, incidence, and sexual risk for HIV among young Asian and Pacific Islander men who have sex with men, San Francisco. Sex Transm Dis 2004; 31:475-480.
28. Wasserheit JN. Epidemiological synergy: Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19: 61-77.
29. Page-Shafer K, Veugelers PJ, Moss AR, et al. Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994. Am J Epidemiol 1997; 146:531-542.
30. Truong HM, Grant RM, McFarland W, et al. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS 20:2193-2197.
31. Chesney MA, Barrett DC, Stall R. Histories of substance use and risk behavior: Precursors to HIV seroconversion in homosexual men. Am J Public Health 1998; 88:113-116.
32. Burcham JL, Tindall B, Marmor M, et al. Incidence and risk factors for human immunodeficiency virus seroconversion in a cohort of Sydney homosexual men. Med J Aust 1989; 150:634-639. (Pubitemid 19193776)
33. Golden MR, Brewer DD, Kurth A, et al. Importance of sex partner HIV status in HIV risk assessment among men who have sex with men. J Acquir Immune Defic Syndr 2004; 36:734-742.
34. Brown EL, Wald A, Hughes JP, et al. High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study. Am J Epidemiol 2006; 164:733-741.
35. Shoptaw S, Reback CJ, Freese TE. Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. J Addict Dis 2002; 21:91-105.
36. Romanelli F, Smith KM, Thornton AC, et al. Poppers: Epidemiology and clinical management of inhaled nitrite abuse. Pharma-cotherapy 2004; 24:69-78.
37. Colfax GN, Mansergh G, Guzman R, et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: A venue-based comparison. J Acquir Immune Defic Syndr 2001; 28:373-379.
38. Reback CJ. The Social Construction of a Gay Drug: Metham-phetamine Use Among Gay and Bisexual Males in Los Angeles. Los Angeles, CA: City of Los Angeles, 1997.
39. Schwarcz S, Scheer S, McFarland W, et al. Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health 2007; 97:1067-1075.
40. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov B, Csaki F, eds. Second International Symposium on Inference Theory. Budapest, Hungary: Akademiai Kiado, 1973:267-281.
41. Hosmer DW, Lemeshow S. Applied Survival Analysis. New York, NY: Wiley, 1999.
42. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994:515-526.
43. Griffin JT, Fraser C, Gras L, et al. The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databases. Am J Epidemiol 2006; 163:676-683.
44. Lindsey JC, Ryan LM. Tutorial in biostatistics methods for interval-censored data. Stat Med 1998; 17:219-238.
45. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20:37-46.
46. Koblin B, Chesney M, Coates T. Effects of a behavioral intervention to reduce acquisition of HIV infection among men who have sex with men: The EXPLORE randomized controlled study. Lancet 2004; 364:41-50.
47. Harrell FE Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer-Verlag, 2001.
48. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56:337-344.
49. Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics 2005; 61:92-105.
50. Justice AC, Covinsky KE, Berlin JA. Assessing the generaliz-ability of prognostic information. Ann Intern Med 1999; 130: 515-524.
51. Reilly BM, Evans AT. Translating clinical research into clinical practice: Impact of using prediction rules to make decisions. Ann Intern Med 2006; 144:201-209.
52. Kamb ML, Fishbein M, Douglas JM Jr, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998; 280:1161-1167.
53. Imrie J, Stephenson JM, Cowan FM, et al. A cognitive behavioural intervention to reduce sexually transmitted infections among gay men: Randomized trial. BMJ 2001; 322:1451-1456.
54. Pepe MS, Janes H, Longton G, et al. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 2004; 159:882-890.
55. Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ 1999; 319:1562-1565.
56. Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med 2006; 355:2615-2617.
57. D'Agostino RB Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001; 286:180-187.
58. MacKellar DA, Valleroy LA, Secura GM, et al. Repeat HIV testing, risk behaviors, and HIV seroconversion among young men who have sex with men: A call to monitor and improve the practice of prevention. J Acquir Immune Defic Syndr 2002; 29:76-85.
59. Kellerman SE, Lehman JS, Lansky A, et al. HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr 2002; 31:202-210.